Title: Key Large Cap Reports to Watch This Week
Date: 2025-04-15 15:00
URL: https://finance.yahoo.com/news/key-large-cap-reports-watch-150000362.html?.tsrc=rss

Content:
Oops, something went wrongTip: Try a valid symbol or a specific company name for relevant resultsOops, something went wrongWhy your water bill is an inflation problem that isn't budgingStock market today: Dow, S&P 500, Nasdaq futures fall as Nvidia reveals costly limits on China exportsThe Treasury secretary told Yahoo Finance that the next 90 days should provide 'substantial clarity' on tariffsTreasury Secretary Scott Bessent tells Yahoo Finance that the US has a 'big toolkit' to deal with bond market volatilityStocks drift lower as tariff chaos pauses for a dayThe chip giant committed to building AI infrastructure in the US, and Trump says he's going to help make it happen.The fallout from Trump's tariff whiplash hasn't yet pushed investors to shy away from an old habitStocks edge higher after back-to-back rallies with Trump's latest tariff moves in focusBofA's Moynihan says 'we potentially face a changing economy' after highest-ever equities trading haulThe trade war uncovers new economies of scaleTrump is wrecking his own economic agendaHigher clothing costs from tariffs are coming soon — but not immediately, experts sayWhy Tesla, GM, and Rivian will be hurt most by China's critical minerals export banTrump says he's 'looking at something' to help car companies with tariffsStocks rally for second straight day, while Apple jumps on tech tariff reprieveThe Nasdaq briefly turned red as stocks' relief rally failed to hold in early afternoon tradingAmericans are braced for the biggest unemployment rate jump since the pandemic, a New York Fed survey foundStocks surge as Apple leads way higher after tech's tariff reprieveTrump's temporary tech tariff respite adds to a growing sense that he has a willingness to listen and bendGoldman CEO Solomon warns of 'markedly different operating environment' as dealmaking slowsCorporate earnings take center stage amid tariff turmoil: What to know this weekTrump has tariffs, taxes, and the debt ceiling on a collision course for this summerTrump denies that there was a tariff “exception” for certain electronics announced Friday. (Bloomberg)Tax day 2025 is coming up. Here’s what to know to file by the deadline.Commentary: Put the P/E ratio in timeout for nowMarket chaos signals 'sell America' trade as Trump tariff whipsaw threatens to upend the US economy's soft landingApple was on brink of crisis before tariff concession from Trump (Bloomberg)Corporate earnings take center stage amid tariff turmoil: What to know this weekThe best (and worst) time of year to buy a houseThe Trump family is going all-in on crypto projects, from Bitcoin mining to stablecoins (Bloomberg)How to invest in gold in 4 stepsChanging jobs can disrupt saving for retirement. Here's how to stay on track.Trump exempts phones, computers, chips from ‘reciprocal’ tariffs (Bloomberg)Meet Walmart heir Steuart Walton, the most powerful board member you’ve never heard ofThe tariff uncertainty isn't getting any better in markets: Chart of the Week'T-shirts could be the new eggs': Why Trump's chaotic tariff whipsaw is still a huge threat to inflationGold notches best week since 2020 amid 'shaken' investor confidence in USThe bond market just had one of its most volatile and unusual weeks in recent memoryStocks capped a wild week with a surge higher, as the S&P 500 posted its biggest weekly gain since 2023Stocks swung into rally mode in afternoon trading, with the major indexes all up over 1%. Bond yields pared bigger gains.The major indexes whipsawed to end a volatile week. Treasury yields surged in signs of more instability in the bond market.Consumer sentiment craters further as inflation expectations soar to highest since 1981Dow, S&P 500, Nasdaq slide as China hits US with tariff hike, bank earnings roll inJPMorgan's Dimon says economy is facing 'considerable turbulence'Tariff uncertainty muddies — and refocuses — earnings seasonChina raises tariffs on US goods to 125% from the 84% planned in response to Trump's latest hikeChina already knows Trump's breaking point in their burgeoning trade war, our columnist writesHow the bond market helped make Trump blink on tariffsThe Dow fell 1,000 points, and the S&P 500 and Nasdaq were crushed as stocks resumed a tariff-fueled sell-offTrump's total tariff on China is actually 145%, the White House said, an amount higher than the 125% previously reportedUnlock stock picks and a broker-level newsfeed that powers Wall Street.Earnings season is always exciting for investors, with companies finally pulling the curtain back and unveiling what’s happened behind the scenes. Guidance is notably more critical this reporting cycle, given the recent tariff-induced spooks that we’ve become accustomed to.Importantly, several notable large-cap stocks are reporting this week, a list that includes Progressive PGR and UnitedHealth UNH. As shown below, PGR and UNH shares have shown great relative strength in 2025.Image Source: Zacks Investment ResearchLet’s take a closer look at what to expect from each.UnitedHealth Group offers a full spectrum of health benefits, with its Optum segment using data and technology to improve care delivery and health outcomes.UNH is currently a Zacks Rank #2 (Buy), with the earnings estimate revisions trend for its upcoming release largely stable over recent months. Top line revisions have also primarily remained stable, with the company expected to see 5% EPS growth on 11% higher sales.Image Source: Zacks Investment ResearchShares presently trade at a 19.5X forward 12-month earnings multiple, in line with the five-year median and beneath a 26.6X five-year high. The current PEG ratio works out to 1.6X, above the 1.4X five-year median and off modestly from 1.9X five-year highs.Image Source: Zacks Investment ResearchProgressive is one of the largest auto and property insurers in the U.S., known for its direct-to-consumer model and strong underwriting performance. The company offers various insurance products, including auto, home, renters, and commercial lines.The stock is currently a Zacks Rank #2 (Buy), with earnings expectations moving higher across the board. As shown below, the revisions trend for the upcoming print has been notably bullish, up 27% over the last 60 days.Image Source: Zacks Investment ResearchRevenue revisions have remained stagnant, with PGR expected to see a big 27% year-over-year increase in EPS on nearly 20% higher sales. The company has been a star earnings performer overall, exceeding the Zacks Consensus EPS estimate by an average of 18% across its last four releases.Shares presently trade at a 17.6X forward 12-month earnings multiple, which compares to a 19.3X five-year median and 31.9X five-year highs. The stock sports a Style Score of ‘C’ for Value.Image Source: Zacks Investment ResearchBottom LineThe 2025 Q1 earnings season picks up considerably this week, with large-cap companies Progressive PGR and UnitedHealth UNH partly headlining the reporting docket.Guidance will be key from both companies, but it’s worth mentioning that both companies are largely insulated from tariff worries thanks to their domestic operations, reflecting a key differentiator in today’s political climate.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportUnitedHealth Group Incorporated (UNH) : Free Stock Analysis ReportThe Progressive Corporation (PGR) : Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWe came across a bullish thesis on UnitedHealth Group Incorporated (UNH) on Substack by Oguz Erkan. In this article, we will summarize the bulls’ thesis on UNH. UnitedHealth Group Incorporated (UNH)’s share was trading at $587.06 as of April 14th. UNH’s trailing and forward P/E were 37.85 and 19.72 respectively according to Yahoo Finance. UnitedHealth Group stands […]Verve Therapeutics stock rises on demonstrating superior LDL-C lowering ability in a phase Ib study of VERVE-102 in patients with HeFH and/or CAD.CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now? Let's take a closer look.In the closing of the recent trading day, Verizon Communications (VZ) stood at $44.48, denoting a +0.41% change from the preceding trading day.Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best pharma stocks to buy for long term growth. U.S. Pharma Turns to China for Drug Deals With big […]PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.On Monday, Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the U.S. The seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits 51746517. Lot number PAR0362 is an authentic lot number. Only when the lot number is coupled with the eight digits 51746517 it is counterfeit and should not be used. AlsWe recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best pharma stocks to buy for long term growth. U.S. Pharma Turns to China for Drug Deals With big American […]The Dow Jones rose on the stock market today and auto stocks popped after President Donald Trump spoke out. Palantir stock was higher while Nvidia fell.Tip: Try a valid symbol or a specific company name for relevant resultsSign in to access your portfolio


Try again.
